IRulya Therapeutics Inc.
IRLA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by IRulya Therapeutics Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q3 2026, worth $66.8M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in IRulya Therapeutics Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +6 vs. Q2 2026
- Shares held
- 2.22M
- +1.89M (+573.7%) vs. Q2 2026
- Total value
- $66.8M
- +$62.0M (+1,308.2%) vs. Q2 2026
- New holders
- 10
- 14 more added
- Sold out
- 4
- 4 more reduced
1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 32 | $66.8M |
| Q2 2026 | 27 | $4.74M |
| Q1 2026 | 48 | $1.45M |
| Q4 2025 | 69 | $67.8M |
| Q3 2025 | 46 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 37 | $6.96M |
| Q4 2024 | 36 | $9.56M |
| Q3 2024 | 34 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding IRulya Therapeutics Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 1,714,957 | $53.2M | 0.02% | +1,714,957 | New |
| Ikarian Capital, LLC | 95,652 | $2.97M | 0.59% | +23,401+32.4% | Added |
| Squadron Capital Management LLC | 90,000 | $2.79M | 0.83% | +49,625+122.9% | Added |
| Millennium Management LLC | 72,254 | $2.24M | 0.00% | +1,475+2.1% | Added |
| Acuta Capital Partners, LLC | 52,918 | $1.64M | 1.27% | +52,918 | New |
| Birchview Capital, LP | 40,601 | $1.26M | 0.73% | +40,601 | New |
| Boothbay Fund Management, LLC | 21,291 | $660.2K | 0.01% | +7,380+53.1% | Added |
| Jane Street Group, LLC | 20,156 | $625.0K | 0.00% | +7,514+59.4% | Added |
| Seven Fleet Capital Management LP | 11,989 | $371.8K | 0.07% | +11,989 | New |
| Geode Capital Management, LLC | 9,741 | $302.1K | 0.00% | +9,741 | New |
| Vanguard Capital Management LLC | 9,216 | $285.8K | 0.00% | −2,828−23.5% | Reduced |
| Cormorant Asset Management, LP | 5,498 | $170.5K | 0.01% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 5,372 | $166.6K | 0.00% | +1,758+48.6% | Added |
| BlackRock, Inc. | 1,689 | $52.4K | 0.00% | −13−0.8% | Reduced |
| JPMorgan Chase & Co | 792 | $24.7K | 0.00% | +790+39,500.0% | Added |
| Morgan Stanley | 794 | $24.6K | 0.00% | −3,290−80.6% | Reduced |
| Wells Fargo & Company | 314 | $9.74K | 0.00% | +304+3,040.0% | Added |
| Group One Trading, L.P. | 234 | $7.26K | 0.00% | +234 | New |
| Gen-Wealth Partners Inc | 166 | $5.15K | 0.00% | +1+0.6% | Added |
| Fortitude Family Office, LLC | 41 | $1.27K | 0.00% | +1+2.5% | Added |
| BFC Planning, Inc. | 15 | $465 | 0.00% | +1+7.1% | Added |
| BNP Paribas Arbitrage, SA | 9 | $279 | 0.00% | +9 | New |
| Allworth Financial LP | 8 | $249 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 6 | $186 | 0.00% | +3+100.0% | Added |
| UBS Group AG | 4 | $124 | 0.00% | −4,726−99.9% | Reduced |
| JDM Financial Group LLC | 2 | $62 | 0.00% | +1+100.0% | Added |
| Advisor Group Holdings, Inc. | 2 | $62 | 0.00% | +2 | New |
| Westside Investment Management, Inc. | 1 | $31 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1 | $31 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $31 | 0.00% | +1 | New |
| Jones Financial Companies LLLP | 1 | $31 | 0.00% | +1 | New |
| Balyasny Asset Management LLC | 69,970 | – | – | +30.0% | Added |
| Shay Capital LLC | 0 | $0 | 0.00% | −17,468−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −567−100.0% | Sold out |
| Operose Advisors LLC | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Royal Bank of Canada | – | – | – | – | Not filed |